Financial Snapshot

Revenue
$109.9K
TTM
Gross Margin
74.36%
TTM
Net Earnings
-$753.2K
TTM
Current Assets
$242.6K
Q3 2021
Current Liabilities
$8.579M
Q3 2021
Current Ratio
2.83%
Q3 2021
Total Assets
$396.5K
Q3 2021
Total Liabilities
$8.579M
Q3 2021
Book Value
-$8.182M
Q3 2021
Cash
$6.980K
Q3 2021
P/E
-0.05311
May 15, 2024 EST
Free Cash Flow
$61.60K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $40 Thousand

About Advanced Biomedical Technologies Inc.

Advanced BioMedical Technologies, Inc. engages in the business of designing, developing, manufacturing, and marketing biomaterial internal fixation devices. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies Peers: ABBOTT LABORATORIES Bionik Laboratories Corp. ThermoGenesis Holdings, Inc. CYduct Diagnostics, Inc. INVIVO THERAPEUTICS HOLDINGS CORP. ECGI Holdings, Inc. ENCISION INC Wellness Center USA, Inc.